Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ART4215 |
Synonyms | |
Therapy Description |
ART4215 inhibits DNA polymerase theta and prevents DNA damage repair, potentially leading to enhanced sensitivity to DNA damaging agents (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ART4215 | ART-4215|ART 4215 | ART4215 inhibits DNA polymerase theta and prevents DNA damage repair, potentially leading to enhanced sensitivity to DNA damaging agents (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04991480 | Phase Ib/II | ART4215 + Talazoparib ART4215 | A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors | Active, not recruiting | USA | GBR | 0 |